A detailed history of Castle Hook Partners LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Castle Hook Partners LP holds 399,059 shares of LLY stock, worth $408 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
399,059
Previous 105,450 278.43%
Holding current value
$408 Million
Previous $82.2 Million 270.41%
% of portfolio
1.71%
Previous 0.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$625.65 - $812.69 $184 Million - $239 Million
293,609 Added 278.43%
399,059 $304 Million
Q2 2025

Aug 14, 2025

SELL
$713.71 - $898.95 $150 Million - $189 Million
-209,857 Reduced 66.56%
105,450 $82.2 Million
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $163 Million - $209 Million
224,981 Added 249.08%
315,307 $260 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $65.7 Million - $84.2 Million
90,326 New
90,326 $69.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Castle Hook Partners LP Portfolio

Follow Castle Hook Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Hook Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Castle Hook Partners LP with notifications on news.